# Effect of fat deposition on placental function in Shaziling sows and modulation by resveratrol

**Authors:** Xizi Yang, Ruizhi Hu, Wentao Zhang, Mingkun Shi, Zhiyong Fan, Xi He, Chenxing Fu, Liang Chen, Hongfu Zhang, Xupeng Yuan, Maisheng Wu, Yulian Li, Hong Tan, Jianhua He, Shusong Wu

PMC · DOI: 10.1016/j.aninu.2025.08.009 · Animal Nutrition · 2025-12-06

## TL;DR

Excess fat in sows harms reproductive performance, but resveratrol improves placental function and litter outcomes.

## Contribution

Resveratrol's role in rescuing placental function and reproductive performance in overweight sows is demonstrated.

## Key findings

- HBT sows had reduced litter and placental performance, which resveratrol significantly improved.
- Resveratrol increased placental vascular density and nutrient transport gene expression in HBT sows.
- Resveratrol restored key signaling pathways like PI3K/AKT/mTOR in placenta of HBT sows.

## Abstract

Excessive fat deposition is considered as an important factor impairing reproductive performance in sows, and resveratrol (RES) has shown a hypolipidemic effect in previous studies. This study aimed to investigate the impact of fat deposition on reproductive performance of Shaziling sows, and further clarify the intervention by RES. Fifty-six lard-type Shaziling sows at 75 d of gestation (G75d) were divided into four groups (n = 14) based on backfat thickness (BT): backfat thickness between 20 to 24 mm (NBT) and backfat thickness between 26 to 30 mm (HBT). The NBT-CTL and HBT-CTL groups were fed a basal diet, while NBT-RES and HBT-RES were fed a diet containing 500 mg/kg RES until delivery. Results showed that HBT sows had lower total litter weight (P = 0.008), average weight of total births (P < 0.001), live litter weight (P < 0.001), average weight of live birth (P < 0.001), and placental efficiency (P = 0.013), but higher average process of farrowing (P < 0.001) and stillbirth (P = 0.005), while RES recovered these indicators significantly. In addition, HBT sows showed lower placental vascular density with decreased fluorescence intensity of platelet endothelial cell adhesion molecule-1 (CD31; P = 0.006) and fibroblast growth factor (FGF; P = 0.001), and expression of nutrient transport genes including sodium coupled neutral amino acid transporter 1 (SNAT1; P = 0.029), cluster of differentiation 36 (CD36; P = 0.004). RES increased nutrient transport genes including glucose transporter protein 3 (GLUT3; P < 0.001), GLUT4 (P = 0.014), cationic amino acid transporter 1 (CAT-1; P = 0.005), SNAT2 (P = 0.015), and plasma membrane fatty acid binding protein (FABPpm; P = 0.009), but increased placental vascular density by increasing the expression of placental angiogenesis (FGF; P = 0.013), placental growth factor (PlGF; P < 0.001) and vascular endothelial growth factor (VEGF-A; P = 0.013) in placenta. Additionally, RES recovered the phosphorylation of phosphoinositide 3-kinase (PI3K; P < 0.001), protein kinase B (AKT; P < 0.001), and mammalian target of rapamycin (mTOR; P < 0.001) in placenta of HBT sows. These findings suggest that excessive fat deposition can impair reproductive performance, which is rescued by RES by increasing the expression of placental nutrient transport and angiogenesis genes in lard-type Shaziling sows, and PI3K may play an important role.

## Linked entities

- **Genes:** PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175], FGF (fibroblast growth factor) [NCBI Gene 582058], SLC38A1 (solute carrier family 38 member 1) [NCBI Gene 81539], CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948], SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 6515], SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517], CRAT (carnitine O-acetyltransferase) [NCBI Gene 1384], SLC38A2 (solute carrier family 38 member 2) [NCBI Gene 54407], Got2 (glutamatic-oxaloacetic transaminase 2, mitochondrial) [NCBI Gene 14719], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], PGF (placental growth factor) [NCBI Gene 5228], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422]
- **Chemicals:** resveratrol (PubChem CID 5056)

## Full-text entities

- **Genes:** Pgf (placental growth factor) [NCBI Gene 18654] {aka PIGF, Plgf}, FGFR1 (fibroblast growth factor receptor 1) [NCBI Gene 2260] {aka BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 100127359] {aka FRAP1}, SLC38A2 (solute carrier family 38 member 2) [NCBI Gene 54407] {aka ATA2, PRO1068, SAT2, SNAT2}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 6515] {aka GLUT3}, HDL (HDL cholesterol) [NCBI Gene 100859998], SLC7A1 (solute carrier family 7 member 1) [NCBI Gene 6541] {aka ATRC1, CAT-1, ERR, HCAT1, REC1L}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 100145903] {aka AMPK, AMPK1}, SLC38A2 (solute carrier family 38 member 2) [NCBI Gene 100525644] {aka SNAT2}, Pik3ca (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 18706] {aka 6330412C24Rik, caPI3K, p110, p110alpha}, HDL (HDL cholesterol) [NCBI Gene 100325635], PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, TNF (tumor necrosis factor) [NCBI Gene 397086] {aka TNFSF2, TNFa}, GOT2 (glutamic-oxaloacetic transaminase 2) [NCBI Gene 396968], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Angpt2 (angiopoietin 2) [NCBI Gene 11601] {aka Agpt2, Ang-2, Ang2}, Ang2 (angiogenin, ribonuclease A family, member 2) [NCBI Gene 11731] {aka Angrp, Raa3, Rnase5b}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 397157] {aka VEGF}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 397013] {aka PGC1, PGC1A, PPARGC-1, PPARGC1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, GOT2 (glutamic-oxaloacetic transaminase 2) [NCBI Gene 2806] {aka DEE82, KAT4, KATIV, KYAT4, mitAAT}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948] {aka BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV}, PlGF [NCBI Gene 541591], INS (insulin) [NCBI Gene 397415], CAT (catalase) [NCBI Gene 397568], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 396754] {aka GLUT4}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 100626468] {aka GLUT-3, GLUT3}, NRF-1 [NCBI Gene 100739649], SLC7A1 (solute carrier family 7 member 1) [NCBI Gene 503545] {aka CAT-1}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 396941] {aka CD31, PECAM-1}, PGF (placental growth factor) [NCBI Gene 100156404], Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, peroxisome proliferator-activated receptor gamma coactivator-1 alpha [NCBI Gene 497232], SLC38A1 (solute carrier family 38 member 1) [NCBI Gene 81539] {aka ATA1, NAT2, SAT1, SNAT1}, Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, IL6 (interleukin 6) [NCBI Gene 399500] {aka IL-6}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 100126861] {aka Akt, PKB}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, KDR (kinase insert domain receptor) [NCBI Gene 397311] {aka FLK-1}
- **Diseases:** placental insufficiency (MESH:D010927), placental dysplasia and dysfunction (MESH:D010922), insulin resistance (MESH:D007333), toxicity (MESH:D064420), stillbirth (MESH:D050497), chronic (MESH:D002908), metabolic syndrome (MESH:D024821), IUGR (MESH:D005317), Inflammation (MESH:D007249), mitochondrial dysfunction (MESH:D028361)
- **Chemicals:** H&amp;E (MESH:D006371), TBS (-), Glycerol (MESH:D005990), Hematoxylin (MESH:D006416), vitamin B1 (MESH:D013831), vitamin D3 (MESH:D002762), vitamin K (MESH:D014812), phosphotyrosine (MESH:D019000), MDA (MESH:D008315), Se (MESH:D012643), rhamsan gum (MESH:C071623), vitamin B2 (MESH:D012256), vitamin B5 (MESH:D010205), polyphenol (MESH:D059808), I (MESH:D007455), vitamin B12 (MESH:D014805), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), diacylglycerol (MESH:D004075), PVDF (MESH:C024865), eosin (MESH:D004801), vitamin B6 (MESH:D025101), vitamin B9 (MESH:D005492), calcium (MESH:D002118), formalin (MESH:D005557), Mn (MESH:D008345), glucose (MESH:D005947), 4',6-diamidino-2-phenylindole (MESH:C007293), flavonoid (MESH:D005419), T (MESH:D014316), fat (MESH:D005223), paraffin (MESH:D010232), oxygen (MESH:D010100), Zn (MESH:D015032), phosphorus (MESH:D010758), EDTA (MESH:D004492), nitrogen (MESH:D009584), vitamin E (MESH:D014810), xylene (MESH:D014992), polyacrylamide (MESH:C016679), TG (MESH:D014280), stilbene (MESH:D013267), vitamin B3 (MESH:D009536), water (MESH:D014867), Oil red O (MESH:C011049), vitamin A (MESH:D014801), Fe (MESH:D007501), isopropanol (MESH:D019840), SDS (MESH:D012967), Cu (MESH:D003300), vitamin B7 (MESH:D001710), RES (MESH:D000077185), ceramide (MESH:D002518), ethanol (MESH:D000431), cholesterol (MESH:D002784)
- **Species:** Polygonum cuspidatum (species) [taxon 83819], Mus musculus (house mouse, species) [taxon 10090], Arachis hypogaea (goober, species) [taxon 3818], Sus scrofa (pig, species) [taxon 9823]
- **Mutations:** (I) for 10, (I) for 5, A013M
- **Cell lines:** 0422O1 — Homo sapiens (Human), 22q11.2 deletion syndrome, Transformed cell line (CVCL_8B57)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914803/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914803/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914803/full.md

---
Source: https://tomesphere.com/paper/PMC12914803